| 000 | 01735 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514192623.0 | ||
| 264 | 0 | _c20040806 | |
| 008 | 200408s 0 0 eng d | ||
| 022 | _a0022-1317 | ||
| 024 | 7 |
_a10.1099/vir.0.79949-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuisman, Willem | |
| 245 | 0 | 0 |
_aAntibodies specific for hypervariable regions 3 to 5 of the feline immunodeficiency virus envelope glycoprotein are not solely responsible for vaccine-induced acceleration of challenge infection in cats. _h[electronic resource] |
| 260 |
_bThe Journal of general virology _cJul 2004 |
||
| 300 |
_a1833-1841 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Viral _ximmunology |
| 650 | 0 | 4 | _aAntibody Specificity |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aCats |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aComplementarity Determining Regions _ximmunology |
| 650 | 0 | 4 | _aDNA Primers |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aFeline Acquired Immunodeficiency Syndrome _ximmunology |
| 650 | 0 | 4 |
_aImmunodeficiency Virus, Feline _ximmunology |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _ximmunology |
| 650 | 0 | 4 | _aRestriction Mapping |
| 650 | 0 | 4 |
_aVaccines, DNA _ximmunology |
| 650 | 0 | 4 |
_aVaccines, Synthetic _ximmunology |
| 650 | 0 | 4 |
_aViral Envelope Proteins _xgenetics |
| 650 | 0 | 4 | _aViral Vaccines |
| 700 | 1 | _aSchrauwen, Eefje J A | |
| 700 | 1 | _aPas, Suzan D | |
| 700 | 1 | _aKarlas, Jos A | |
| 700 | 1 | _aRimmelzwaan, Guus F | |
| 700 | 1 | _aOsterhaus, Albert D M E | |
| 773 | 0 |
_tThe Journal of general virology _gvol. 85 _gno. Pt 7 _gp. 1833-1841 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1099/vir.0.79949-0 _zAvailable from publisher's website |
| 999 |
_c14923264 _d14923264 |
||